Literature DB >> 18710402

Intracellular concentrations of Ca(2+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/CD86 interactions in CD4(+) T lymphocytes.

Asma Ahmed1, Sambuddho Mukherjee, Dipankar Nandi.   

Abstract

The costimulatory receptors CD28 and cytotoxic T-lymphocyte antigen (CTLA)-4 and their ligands, CD80 and CD86, are expressed on T lymphocytes; however, their functional roles during T cell-T cell interactions are not well known. The consequences of blocking CTLA-4-CD80/CD86 interactions on purified mouse CD4(+) T cells were studied in the context of the strength of signal (SOS). CD4(+) T cells were activated with phorbol 12-myristate 13-acetate (PMA) and different concentrations of a Ca(2+) ionophore, Ionomycin (I), or a sarcoplasmic Ca(2+) ATPase inhibitor, Thapsigargin (TG). Increasing concentrations of I or TG increased the amount of interleukin (IL)-2, reflecting the conversion of a low to a high SOS. During activation with PMA and low amounts of I, intracellular concentrations of calcium ([Ca(2+)](i)) were greatly reduced upon CTLA-4-CD80/CD86 blockade. Further experiments demonstrated that CTLA-4-CD80/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS). These results were confirmed by surface T-cell receptor (TCR)-CD3 signalling using a low SOS, for example soluble anti-CD3, or a high SOS, for example plate-bound anti-CD3. Also, CTLA-4-CD80/CD86 interactions enhanced the generation of reactive oxygen species (ROS). Studies with catalase revealed that H(2)O(2) was required for IL-2 production and cell cycle progression during activation with a low SOS. However, the high amounts of ROS produced during activation with a high SOS reduced cell cycle progression. Taken together, these results indicate that [Ca(2+)](i) and ROS play important roles in the modulation of T-cell responses by CTLA-4-CD80/CD86 interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710402      PMCID: PMC2669817          DOI: 10.1111/j.1365-2567.2008.02902.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

Review 1.  Calcium signaling mechanisms in T lymphocytes.

Authors:  R S Lewis
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  CTLA-4 regulates induction of anergy in vivo.

Authors:  R J Greenwald; V A Boussiotis; R B Lorsbach; A K Abbas; A H Sharpe
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

3.  Weak TCR stimulation induces a calcium signal that triggers IL-4 synthesis, stronger TCR stimulation induces MAP kinases that control IFN-gamma production.

Authors:  A Badou; M Savignac; M Moreau; C Leclerc; G Foucras; G Cassar; P Paulet; D Lagrange; P Druet; J C Guéry; L Pelletier
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

4.  Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength.

Authors:  Jackson G Egen; James P Allison
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

5.  Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population.

Authors:  D E Anderson; K D Bieganowska; A Bar-Or; E M Oliveira; B Carreno; M Collins; D A Hafler
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

6.  CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen.

Authors:  Lucy S K Walker; Lara J Ausubel; Anna Chodos; Nyree Bekarian; Abul K Abbas
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 7.  The reverse stop-signal model for CTLA4 function.

Authors:  Christopher E Rudd
Journal:  Nat Rev Immunol       Date:  2008-02       Impact factor: 53.106

8.  Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.

Authors:  Sambuddho Mukherjee; Prasanta K Maiti; Dipankar Nandi
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

9.  Thapsigargin-induced apoptosis involves Cabin1-MEF2-mediated induction of Nur77.

Authors:  W Liu; H D Youn; J O Liu
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

Review 10.  CTLA-4: new insights into its biological function and use in tumor immunotherapy.

Authors:  Jackson G Egen; Michael S Kuhns; James P Allison
Journal:  Nat Immunol       Date:  2002-07       Impact factor: 25.606

View more
  3 in total

1.  Surfactant protein A integrates activation signal strength to differentially modulate T cell proliferation.

Authors:  Sambuddho Mukherjee; Charles Giamberardino; Joseph Thomas; Kathy Evans; Hisatsugu Goto; Julie G Ledford; Bethany Hsia; Amy M Pastva; Jo Rae Wright
Journal:  J Immunol       Date:  2012-01-04       Impact factor: 5.422

Review 2.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy.

Authors:  Dipankar Nandi; Sanmoy Pathak; Taru Verma; Madhulika Singh; Avik Chattopadhyay; Samriddhi Thakur; Abinaya Raghavan; Abhijeet Gokhroo
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

3.  Aberrant Peripheral Immune Function in a Good Syndrome Patient.

Authors:  Xian Chen; Jie-Xin Zhang; Wen-Wen Shang; Wei-Ping Xie; Shu-Xian Jin; Fang Wang
Journal:  J Immunol Res       Date:  2018-04-23       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.